Cancer-focused research and treatment center City of Hope has significantly boosted its Orange County presence via the acquisition of one of the region’s larger oncology and hematology medical groups.
City of Hope last week announced the addition of Pacific Shores Medical Group, which counts seven locations in OC and Los Angeles counties; local spots are in Huntington Beach, Irvine, and Newport Beach.
Pacific Shores’ 14 physicians, 11 nurse practitioners and physician assistants, and more than 200 staff members have joined the Duarte-based group, which is building a billion-dollar cancer campus at the Great Park Neighborhoods in Irvine.
Terms of the deal were undisclosed. A partnership had been in the works for some time, but its completion was delayed by the onset of the pandemic, officials said.
It brings City of Hope’s cancer care network up to 35 sites in Southern California.
Pacific Shores, founded in 1986, typically counts more than 80,000 patient visits a year, and sees between 4,000 and 5,000 new patients annually, said founder and Chief Executive N. Simon Tchekmedyian, a longtime Huntington Beach resident.
As of three years ago when it was just beginning to ramp up its presence in the area, City of Hope had around 3,000 patients in Orange County, so the Aug. 9 deal represents a significant milestone in terms of boosting the buyer’s ability to provide increased access to local residents, said Annette Walker, president of City of Hope Orange County.
“It’s one of the largest expansions in City of Hope’s history,” Walker said. It will be “so good for the community.”
A primary benefit of the deal is that City of Hope will be better able to deliver advanced cancer care closer to where people in OC live, Walker said. Prior to opening its first outpatient treatment center in Newport Beach at the start of 2020, most City of Hope patients in OC would make a 45-mile or so drive to its main campus in Duarte.
South Bay, LA
The deal is primarily about “doing what’s best for the patient,” said Edward Kim, physician-in-chief at City of Hope OC.
“We’ll be able to provide expertise, and innovative precision medicine closer to where [patients] live,” he said.
In addition to the trio of OC locations, Pacific Shores has two locations in Long Beach, as well as Glendale and Torrance.
Most, if not all, of Pacific Shore’s doctors already collaborate with their peers at City of Hope, so the alignment between the two groups should go smooth, Tchekmedyian said.
City of Hope counts more than 1,000 researchers and physicians, and treats more than 90,000 patients annually.
“We have a common mission, a common goal,” said Pacific Shores’ Tchekmedyian, whose group has been conducting clinical trials for some 35 years. He said he was “delighted” that his group’s existing patients would now have access to the City of Hope’s treatments, trials and doctors.
The Pacific Shores deal adds to a busy period of expansion for City of Hope’s OC operations.
It’s in the midst of building out a comprehensive cancer center at the Great Park Neighborhoods at a 190,000-square-feet office it bought last year.
The center, to be called Lennar Foundation Cancer Center following a $50 million donation earlier this year from the charitable arm of the homebuilding giant (NYSE: LEN), is scheduled to open in the summer of 2022.
The facility will provide diagnostics imaging and screenings, precision medicine, advanced treatment options, access to clinical trials, and personalized support services, among other features.
It will be joined by an adjacent specialty hospital, which is being built from the ground up, and is scheduled to open by 2025.